1. Protein–protein interactions between SWCNT/chitosan/EGF and EGF receptor: a model of drug delivery system
   Chompoonut Rungnim et al, 2016, Journal of Biomolecular Structure and Dynamics CrossRef
2. Synthesis of Diagnostic Silicon Nanoparticles for Targeted Delivery of Thiourea to Epidermal Growth Factor Receptor-Expressing Cancer Cells
   Mehrnaz Behray et al, 2016, ACS Appl. Mater. Interfaces CrossRef
3. Detecting ligand interactions with G protein-coupled receptors in real-time on living cells
   Bo Xu et al, 2013, Biochemical and Biophysical Research Communications CrossRef
4. Comparing the measured affinity of 111In-labeled ligands for cellular receptors by monitoring gamma, beta, or X-ray radiation with three different LigandTracer® devices
   Zohreh Varasteh et al, 2015, J Radioanal Nucl Chem CrossRef
5. Synthesis and photophysical properties of a fluorescent cyanoquinoline probe for profiling ERBB2 kinase inhibitor response
   Heajin Lee et al, 2017, Bioorganic & Medicinal Chemistry CrossRef
6. Transfer of Dyes and Drugs into Cells Using EGFR-Targeted Nanosyringes.
   Lizanne G Nilewski et al, 2018, ACS Chem Neurosci CrossRef
7. Conjugation Effects on Antibody–Drug Conjugates: Evaluation of Interaction Kinetics in Real Time on Living Cells
   Sina Bondza et al, 2014, Mol. Pharmaceutics CrossRef
8. Evaluation of a radiocobalt-labelled affibody molecule for imaging of human epidermal growth factor receptor 3 expression
   Maria Rosestedt et al, 2017 CrossRef
9. Comparative Evaluation of Radioiodine and Technetium-Labeled DARPin 9_29 for Radionuclide Molecular Imaging of HER2 Expression in Malignant Tumors
   Anzhelika Vorobyeva et al, 2018, Contrast Media & Molecular Imaging CrossRef
10. A conformational sensor based on genetic code expansion reveals an autocatalytic component in EGFR activation
    Martin Baumdick et al, 2018, Nat Commun CrossRef
11. Site-specific conjugation of recognition tags to trastuzumab for Peptide Nucleic Acid-mediated radionuclide HER2 pretargeting
    Kristina Westerlund et al, 2019, Biomaterials CrossRef
12. Erlotinib/hydroxypropyl-β-cyclodextrin inclusion complex: characterization and in vitro and in vivo evaluation
    Sávio M. L. Gontijo et al, 2015, J Incl Phenom Macrocycl Chem CrossRef
13. New approaches for the reliable in vitro assessment of binding affinity based on high-resolution real-time data acquisition of radioligand-receptor binding kinetics
    Markus Zeilinger et al, 2017, EJNMMI Res CrossRef
14. EGFR-Specific Tyrosine Kinase Inhibitor Modifies NK Cell-Mediated Antitumoral Activity against Ovarian Cancer Cells
    Nina Mallmann-Gottschalk et al, 2019, IJMS CrossRef
15. Relationship between the agonist activity of synthetic ligands of TRAIL-R2 and their cell surface binding modes
    Neila Chekkat et al, 2018, Oncotarget CrossRef
16. Review on Epidermal Growth Factor Receptor (EGFR) Structure, Signaling Pathways, Interactions, and Recent Updates of EGFR Inhibitors.
    Dima A Sabbah et al, 2020, Curr Top Med Chem CrossRef
17. The complexities of PKCα signaling in cancer
    Adrian R. Black et al, 2020, Advances in Biological Regulation CrossRef
18. Differential effects of epidermal growth factor receptor inhibitors in a single patient with neuropathic pain
    Marte Grønlie Cameron et al, 2021, BMJ Case Rep CrossRef
19. Radionuclide Tumor Targeting Using ADAPT Scaffold Proteins: Aspects of Label Positioning and Residualizing Properties of the Label
    Sarah Lindbo et al, 2018, J Nucl Med CrossRef
20. null
    Khushboo Agrawal et al, 2022 CrossRef
21. Bivalent EGFR-Targeting DARPin-MMAE Conjugates
    Lennard Karsten et al, 2022, IJMS CrossRef
22. Exploring Time-Resolved Characterization of the Heterogeneity and Dynamics of Ligand-Receptor Interactions on Living Cells
    null Pavel Barta et al, 2014, J. Anal. Oncol. CrossRef
23. Cells use molecular working memory to navigate in changing chemoattractant fields
    Akhilesh Nandan et al, 2022 CrossRef
24. Increased EGFRvIII Epitope Accessibility after Tyrosine Kinase Inhibitor Treatment of Glioblastoma Cells Creates More Opportunities for Immunotherapy
    Cezary Tręda et al, 2023, IJMS CrossRef
25. Comparative Evaluation of Two DARPin Variants: Effect of Affinity, Size, and Label on Tumor Targeting Properties.
    Sergey Deyev et al, 2019, Mol Pharm CrossRef
26. Hyaluronic acid hydrogel for controlled release of heterobifunctional photocleavable linker-modified epidermal growth factor in wound healing
    Saebin Lim et al, 2023, International Journal of Biological Macromolecules CrossRef
27. Modulatory effect of pomegranate peel extract on key regulators of ovarian cellular processes in vitro
    Adriana Kolesarova et al, 2023, Front. Endocrinol. CrossRef
28. Different EGF‐induced receptor dimer conformations for signaling and internalization
    Jordi Haubrich et al, 2024, The FASEB Journal CrossRef